T/CAV 012-2025
Active
Group standards
T/CAV 012-2025 Guidelines for the Establishment and Management of Areas for Handling Suspected Adverse Reactions to Vaccinations
T/CAV 012-2025 Guidance on setting and managing specifications for suspected vaccination anomaly response zones
Price:
$ 20.00
Basic Information
Standard Code:
T/CAV 012-2025
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
Medicine, health, and labor protection
ICS Name:
Medical and Health Technology (Vocabulary)
Publish Date:
2025-04-23
Implement Date:
2025-04-23
Scope
Main technical content: 4. Requirements for setting up a suspected adverse reaction to vaccination handling area 5. Management requirements for the suspected adverse reaction to vaccination handling area 6. Handling and reporting of suspected adverse reactions to vaccination Appendix A (Normative): List of items to be provided in the suspected adverse reaction to vaccination handling area Appendix B (Normative): Usage of adrenaline in the suspected adverse reaction to vaccination handling area and flowchart for handling and reporting of adverse events following immunization (AEFI) Appendix C (Normative): Suspected adverse reaction to vaccination registration form
Development Information
Related Standards
GB/T 17857-1999
Active
GB 18466-2001
Replaced
GB 18466-2001 Requirements for medical organization sewage discharge
GB 18467-2001
Replaced
GB 18467-2001 Health examination criteria of blood donors
GB 18469-2001
Replaced
GB 18469-2001 Standards for whole blood and blood components quality
WS 233-2002
Abolished
WS 233-2002 General biosafety standard for microbiological and biomedical laboratories
YY/T 0468-2003
Replaced